When investors and analysts need to determine what a company is truly worth, they rely on a toolkit of valuation methodologies. Each approach offers unique insights and serves different purposes depending on market conditions, company maturity, and available data. Understanding how these methods interrelate transforms how you interpret financial forecasts and market pricing.

The most theoretically rigorous approach is discounted cash flow valuation, which projects a company's future cash flows and discounts them back to present value. The core idea is straightforward: money available today is worth more than the same amount in the future, so you must apply a discount rate that reflects the opportunity cost of capital. For dividend-paying companies, the dividend discount model simplifies DCF by focusing exclusively on dividends shareholders actually receive, rather than free cash flow. Both methods hinge on accurately forecasting future cash generation, which is why companies with stable, predictable revenue streams tend to be valued most confidently using these approaches.

The challenge with DCF is determining the appropriate discount rate. This is where the capital asset pricing model enters the picture, providing a framework to estimate the cost of equity based on a company's systematic risk. The CAPM formula accounts for the risk-free rate, the company's beta relative to the broader market, and the equity risk premium—the additional return investors demand for bearing market risk. By adjusting your discount rate according to CAPM, you ensure your DCF valuation reflects the true risk profile of the business.

In practice, however, many investors cross-check DCF valuations with relative valuation methods. Comparable company analysis sidesteps the forecasting burden by looking at how similar publicly traded companies are priced. If comparable firms trade at 15 times earnings and your target company appears stronger, you might justify a premium multiple. This relative approach offers a reality check: even if your DCF analysis suggests a company is worth $100 per share, if similar firms trade at 12 times earnings and your company trades at 25 times earnings, the market may be pricing in expectations you haven't accounted for—or signaling irrational exuberance.

The interplay between these methods is critical. A company's CAPM-derived cost of equity directly feeds into your DCF calculation, making that valuation sensitive to market conditions and perceived risk. Meanwhile, comparable company multiples provide both a sanity check and a negotiating baseline. Strong financial analysts use all three in concert: they forecast cash flows with DCF, anchor those forecasts against peer multiples, and adjust their required return using CAPM to ensure the discount rate is economically defensible.

Different contexts call for different tools. Early-stage, high-growth companies rarely have enough historical data for reliable DCF projections, making comparable analysis or venture capital methods more practical. Mature, stable companies with predictable cash flows reward the effort of detailed DCF modeling. And in M&A scenarios, acquirers often blend all approaches—using DCF for base valuation, comparable multiples for negotiation positioning, and adjusted cost of equity to account for integration risks and synergies.

By learning to toggle between DCF rigor and relative valuation pragmatism, informed investors gain confidence in both their valuations and their ability to spot when markets are pricing companies fairly, expensively, or cheaply relative to fundamentals.